Healthcare provider profile · identity verified

M S Bhagavan, M.D.

Internal Medicine · CHICAGO, IL · NPI 1174512917

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	321	74
Amlodipine Besylate	Amlodipine Besylate	158	38
Gabapentin	Gabapentin	143	25
Eliquis	Apixaban	129	13
Metoprolol Succinate	Metoprolol Succinate	126	30
Lisinopril	Lisinopril	111	18
Levothyroxine Sodium	Levothyroxine Sodium	94	20
Tamsulosin Hcl	Tamsulosin Hcl	83	21
Albuterol Sulfate Hfa	Albuterol Sulfate	78	29
Losartan Potassium	Losartan Potassium	74	22
Furosemide	Furosemide	66	19
Famotidine	Famotidine	65	16
Hydralazine Hcl	Hydralazine Hcl	60	18
Carvedilol	Carvedilol	59	19
Jardiance	Empagliflozin	59	suppressed
Enalapril Maleate	Enalapril Maleate	57	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	51	15
Divalproex Sodium	Divalproex Sodium	47	suppressed
Metformin Hcl	Metformin Hcl	46	11
Levetiracetam	Levetiracetam	43	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	42	19
Omeprazole	Omeprazole	41	suppressed
Buspirone Hcl	Buspirone Hcl	40	suppressed
Metformin Hcl Er	Metformin Hcl	39	suppressed
Trazodone Hcl	Trazodone Hcl	39	suppressed
Clopidogrel	Clopidogrel Bisulfate	37	suppressed
Benztropine Mesylate	Benztropine Mesylate	36	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	34	suppressed
Potassium Chloride	Potassium Chloride	34	suppressed
Alendronate Sodium	Alendronate Sodium	32	suppressed
Fluticasone Propionate	Fluticasone Propionate	32	11
Latanoprost	Latanoprost	32	suppressed
Olanzapine	Olanzapine	32	suppressed
Vascepa	Icosapent Ethyl	30	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	29	suppressed
Trulicity	Dulaglutide	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Ozempic	Semaglutide	27	suppressed
Simvastatin	Simvastatin	26	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Glimepiride	Glimepiride	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	21	suppressed
Naloxone Hcl	Naloxone Hcl	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Valsartan	Valsartan	18	suppressed
Rybelsus	Semaglutide	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	15	suppressed
Cephalexin	Cephalexin	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	15	suppressed
Allopurinol	Allopurinol	14	suppressed
Insulin Lispro	Insulin Lispro	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Baclofen	Baclofen	11	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Digoxin	Digoxin	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Topiramate	Topiramate	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error